The Middle East and North Africa (MENA) region presents a complex cannabis landscape: deep traditional use in some areas, strict prohibition in others, and emerging medical reform in a few. From Morocco’s historic hashish production to Israel’s medical cannabis innovation, the region navigates tensions between cultural heritage, religious values, public health, and geopolitical realities. Understanding MENA’s evolving dynamics reveals both challenges and opportunities in a historically understudied context.
Morocco: Heritage Production and Reform Debates
Morocco has long been a global hashish producer, particularly in the Rif Mountains:
- Traditional cultivation: Cannabis farming supports rural livelihoods and cultural practices dating centuries.
- Legal ambiguity: While prohibition remains, enforcement has been inconsistent, with periodic amnesties for smallholders.
- Reform discussions: Growing debates about legalizing medical or industrial hemp to formalize the sector, create jobs, and reduce illicit trade.
Morocco’s potential transition—from informal production to regulated market—could reshape global supply chains while addressing rural development needs. Success requires balancing tradition with regulation, local interests with international markets.
Israel: Medical Innovation and Export Ambitions
Israel is a global leader in cannabis research and medical innovation:
- Early legalization: Medical cannabis permitted since the 1990s, with a sophisticated regulatory framework.
- Research excellence: Universities and companies pioneering clinical trials, extraction methods, and therapeutic applications.
- Export strategy: Licensed producers targeting European, Australian, and other international medical markets.
Israel’s model emphasizes science, quality, and commercial viability. Challenges include regulatory complexity, competition from lower-cost producers, and geopolitical constraints on trade.
Lebanon & Jordan: Medical Reform Explorations
Other MENA nations are cautiously exploring medical cannabis:
- Lebanon: Legalized medical cannabis cultivation (2020) to support struggling agricultural sectors and generate export revenue. Implementation faces political instability and infrastructure challenges.
- Jordan: Considering medical frameworks, with debates over religious interpretations, public health, and economic opportunity.
These efforts reflect broader regional trends: using cannabis reform for rural development, foreign exchange earnings, and scientific advancement—while navigating cultural and religious sensitivities.
Gulf States: Prohibition, Pilots, and Pragmatism
Gulf Cooperation Council (GCC) countries maintain strict prohibition, but subtle shifts are emerging:
- UAE: Allowed CBD-based pharmaceuticals under tight controls; exploring medical research partnerships.
- Saudi Arabia: Harsh enforcement for recreational use, but growing interest in medical applications within Islamic ethical frameworks.
- Qatar & Kuwait: Similar caution, with emphasis on prevention and treatment over liberalization.
These states balance traditional values, public health priorities, and economic diversification goals. Any reform will likely be gradual, medically focused, and carefully controlled.
Traditional Use & Cultural Context
Cannabis has deep roots in parts of MENA:
- Sufi traditions: Historical use in some mystical practices for meditation and spiritual exploration.
- Folk medicine: Traditional healers using cannabis for pain, anxiety, and various ailments.
- Social rituals: Cannabis consumption in certain communities as part of hospitality and bonding.
Contemporary policy debates increasingly acknowledge these traditions, seeking to balance cultural respect with modern regulatory frameworks.
Geopolitical Complexities & Regional Cooperation
MENA cannabis policy intersects with broader geopolitical dynamics:
- Conflict zones: Cannabis cultivation as livelihood strategy in areas with limited economic alternatives.
- Migration and trafficking: Cross-border flows creating enforcement challenges and humanitarian concerns.
- Regional diplomacy: Limited formal cooperation on cannabis policy, but growing informal exchanges among regulators, researchers, and advocates.
Building trust, sharing knowledge, and aligning incentives could enable more effective, humane regional approaches.
Challenges & Opportunities
MENA’s cannabis transition faces structural hurdles:
- Regulatory capacity: Building institutions for licensing, testing, and enforcement with varying resources.
- Cultural and religious considerations: Navigating diverse interpretations of Islamic law and traditional values.
- Economic pressures: Balancing reform with stability, especially in contexts of unemployment and inequality.
- International obligations: Reconciling domestic reform with UN treaty commitments and donor expectations.
Yet opportunities abound: rural development, medical innovation, scientific advancement, and cultural preservation. With thoughtful design, inclusive dialogue, and respectful partnerships, MENA nations can craft cannabis policies that serve their peoples while contributing to global knowledge.
The Road Ahead
MENA’s cannabis future will likely be gradual, medically focused, and context-specific. By centering public health, economic inclusion, and cultural respect, the region can develop models that honor tradition while embracing evidence. The next decade will test whether reform can advance equity alongside efficiency, and whether regional cooperation can overcome historical divisions.